Nicholas J. Wheeler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicholas J. Wheeler has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Mostafa Zamanian
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
24 shared publications - Kaetlyn T. Ryan
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
9 shared publications - Kendra J. Gallo
University of Wisconsin-Madison
8 shared publications - Chase N. Nelson
Department of Biology, University of Wisconsin-Eau Claire, Eau Claire, WI
5 shared publications - Paul M. Airs
School of Biological Sciences, Queen’s University Belfast, Belfast, UK
5 shared publications - John D. Chan
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
4 shared publications
Latest Publications
- Open Access
Distinct antischistosomal profiles of antimalarials and TRP agonists
Schistosomiasis control relies on praziquantel mass drug administration, but reports of field treatment failure and laboratory-selected resistance highlight the need for alternatives. Praziquantel activates a schistosome transient receptor potential (TRP) channel, TRPM PZQ . Alternative leads or chemotherapies include meclonazepam, which activates a distinct schistosome TRP channel, and the antimalarials artemether and mefloquine, whose flatworm targets are unknown. To compare molecular responses and assess cross-resistance, we conducted comparative RNA-seq and efficacy studies in infected mice. We profiled adult Schistosoma mansoni recovered 48 hours after artemether or mefloquine treatment and compared responses with existing datasets for TRP agonists praziquantel and meclonazepam. Transcriptional profiles clustered by drug class but showed largely distinct changes, with only 33 upregulated and 63 downregulated transcripts shared across treatments. Plexin domain-containing genes were strongly induced by both TRP agonists and, to a lesser extent, by antimalarials. Artemether downregulated gene families expressed in intestinal cells (saposins, cathepsins, and Bax inhibitor-like proteins), consistent with potential heme-dependent activity in the schistosome gut. Genes involved in glutamine metabolism, iron homeostasis and responses to oxidative damage were upregulated across multiple treatments. We evaluated all four treatments in mice infected with praziquantel-susceptible or resistant parasites. Praziquantel (200 mg/kg) reduced resistant male worm burdens by only 39.3%, versus 99.0% in susceptible parasites. Meclonazepam (83.0% versus 91.6% in susceptible parasites), mefloquine (99.1% versus 98.8%), and artemether (98.2% versus 99.4%) retained activity. The distinct transcriptional responses and retained activity against praziquantel-resistant parasites support further investigation of these compound classes as praziquantel alternatives or potential combination partners.
Open AccessDistinct antischistosomal profiles of antimalarials and TRP agonists
Schistosomiasis control relies on praziquantel mass drug administration, but reports of field treatment failure and laboratory-selected resistance highlight the need for alternatives. Praziquantel activates a schistosome transient receptor potential (TRP) channel, TRPM PZQ . Alternative leads or chemotherapies include meclonazepam, which activates a distinct schistosome TRP channel, and the antimalarials artemether and mefloquine, whose flatworm targets are unknown. To compare molecular responses and assess cross-resistance, we conducted comparative RNA-seq and efficacy studies in infected mice. We profiled adult Schistosoma mansoni recovered 48 hours after artemether or mefloquine treatment and compared responses with existing datasets for TRP agonists praziquantel and meclonazepam. Transcriptional profiles clustered by drug class but showed largely distinct changes, with only 33 upregulated and 63 downregulated transcripts shared across treatments. Plexin domain-containing genes were strongly induced by both TRP agonists and, to a lesser extent, by antimalarials. Artemether downregulated gene families expressed in intestinal cells (saposins, cathepsins, and Bax inhibitor-like proteins), consistent with potential heme-dependent activity in the schistosome gut. Genes involved in glutamine metabolism, iron homeostasis and responses to oxidative damage were upregulated across multiple treatments. We evaluated all four treatments in mice infected with praziquantel-susceptible or resistant parasites. Praziquantel (200 mg/kg) reduced resistant male worm burdens by only 39.3%, versus 99.0% in susceptible parasites. Meclonazepam (83.0% versus 91.6% in susceptible parasites), mefloquine (99.1% versus 98.8%), and artemether (98.2% versus 99.4%) retained activity. The distinct transcriptional responses and retained activity against praziquantel-resistant parasites support further investigation of these compound classes as praziquantel alternatives or potential combination partners.
- Open Access
- 29 July 2026
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (7) , e1014485
Deep phenotypic profiling uncovers cryptic effects of antifilarial drugs
The anthelmintics ivermectin, albendazole, and diethylcarbamazine are the backbone of mass drug administration (MDA) campaigns targeting human filariasis, yet their direct effects on parasites are still not fully defined or understood. The clinical effects of these drugs are stage dependent, resulting in effective clearance of circulating microfilariae but only limited activity against adult worms, a pattern that complicates disease surveillance and elimination efforts. Although molecular targets have been identified or proposed for some antifilarial drugs, their precise modes of action remain opaque, and conventional in vitro assays of motility or viability have generally failed to reflect pharmacologically relevant effects. There is growing evidence that cryptic phenotypes involving altered host-parasite interactions, including changes in parasite secretions, may help reconcile these discrepancies. Focusing on the causative species of lymphatic filariasis, we used high content imaging and quantitative mass spectrometry to enable deeper phenotypic profiling of drug responses in microfilariae and adult worms exposed to antifilarial compounds. In microfilariae, altered environmental conditions (temperature and salinity) lead to modest ivermectin effects on motility at therapeutic concentrations. In adult parasites, we show that drug responses vary with worm age and that different anthelmintics induce distinct changes in the secretory proteome. This improved phenotypic resolution advances our understanding of drug action in intra-host stages and highlights how antifilarial drugs can alter secretory cargo relevant to the detection of adult parasites that persist after drug treatment.
- 29 July 2026
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (7) , e1014485
Open AccessDeep phenotypic profiling uncovers cryptic effects of antifilarial drugs
The anthelmintics ivermectin, albendazole, and diethylcarbamazine are the backbone of mass drug administration (MDA) campaigns targeting human filariasis, yet their direct effects on parasites are still not fully defined or understood. The clinical effects of these drugs are stage dependent, resulting in effective clearance of circulating microfilariae but only limited activity against adult worms, a pattern that complicates disease surveillance and elimination efforts. Although molecular targets have been identified or proposed for some antifilarial drugs, their precise modes of action remain opaque, and conventional in vitro assays of motility or viability have generally failed to reflect pharmacologically relevant effects. There is growing evidence that cryptic phenotypes involving altered host-parasite interactions, including changes in parasite secretions, may help reconcile these discrepancies. Focusing on the causative species of lymphatic filariasis, we used high content imaging and quantitative mass spectrometry to enable deeper phenotypic profiling of drug responses in microfilariae and adult worms exposed to antifilarial compounds. In microfilariae, altered environmental conditions (temperature and salinity) lead to modest ivermectin effects on motility at therapeutic concentrations. In adult parasites, we show that drug responses vary with worm age and that different anthelmintics induce distinct changes in the secretory proteome. This improved phenotypic resolution advances our understanding of drug action in intra-host stages and highlights how antifilarial drugs can alter secretory cargo relevant to the detection of adult parasites that persist after drug treatment.
- Open Access
Deep phenotypic profiling uncovers cryptic effects of antifilarial drugs
The anthelmintics ivermectin, albendazole, and diethylcarbamazine are the backbone of mass drug administration (MDA) campaigns targeting human filariasis, yet their direct effects on parasites are still not fully defined or understood. The clinical effects of these drugs are stage dependent, resulting in effective clearance of circulating microfilariae but only limited activity against adult worms, a pattern that complicates disease surveillance and elimination efforts. Although molecular targets have been identified or proposed for some antifilarial drugs, their precise modes of action remain opaque, and conventional in vitro assays of motility or viability have generally failed to reflect pharmacologically relevant effects. There is growing evidence that cryptic phenotypes involving altered host-parasite interactions, including changes in parasite secretions, may help reconcile these discrepancies. Focusing on the causative species of lymphatic filariasis, we used high content imaging and quantitative mass spectrometry to enable deeper phenotypic profiling of drug responses in microfilariae and adult worms exposed to antifilarial compounds. In microfilariae, altered environmental conditions (temperature and salinity) lead to modest ivermectin effects on motility at therapeutic concentrations. In adult parasites, we show that drug responses vary with worm age and that different anthelmintics induce distinct changes in the secretory proteome. This improved phenotypic resolution advances our understanding of drug action in intra-host stages and highlights how antifilarial drugs can alter secretory cargo relevant to the detection of adult parasites that persist after drug treatment.
Open AccessDeep phenotypic profiling uncovers cryptic effects of antifilarial drugs
The anthelmintics ivermectin, albendazole, and diethylcarbamazine are the backbone of mass drug administration (MDA) campaigns targeting human filariasis, yet their direct effects on parasites are still not fully defined or understood. The clinical effects of these drugs are stage dependent, resulting in effective clearance of circulating microfilariae but only limited activity against adult worms, a pattern that complicates disease surveillance and elimination efforts. Although molecular targets have been identified or proposed for some antifilarial drugs, their precise modes of action remain opaque, and conventional in vitro assays of motility or viability have generally failed to reflect pharmacologically relevant effects. There is growing evidence that cryptic phenotypes involving altered host-parasite interactions, including changes in parasite secretions, may help reconcile these discrepancies. Focusing on the causative species of lymphatic filariasis, we used high content imaging and quantitative mass spectrometry to enable deeper phenotypic profiling of drug responses in microfilariae and adult worms exposed to antifilarial compounds. In microfilariae, altered environmental conditions (temperature and salinity) lead to modest ivermectin effects on motility at therapeutic concentrations. In adult parasites, we show that drug responses vary with worm age and that different anthelmintics induce distinct changes in the secretory proteome. This improved phenotypic resolution advances our understanding of drug action in intra-host stages and highlights how antifilarial drugs can alter secretory cargo relevant to the detection of adult parasites that persist after drug treatment.
- 1 January 2026
- Published by American Society of Parasitologists in Journal of Parasitology
- Vol. 112 (3) , 360-367
Tissue-Specific Origin of Eggs in the Definitive Host Drives Transcriptomic and Behavioral Differences in Schistosoma mansoni Miracidia
Schistosomiasis is a neglected tropical disease caused by human-infective schistosomes (Trematoda: Schistosoma). Intestinal schistosomiasis in sub-Saharan Africa and the Neotropics is caused primarily by Schistosoma mansoni and is transmitted by several Biomphalaria planorbid snail species. Adult male and female parasites in the definitive mammalian host pair and reside in the mesenteric vasculature; females lay eggs that traverse the intestinal wall to be excreted, but a significant proportion become trapped in host tissues, especially the liver, eliciting granulomatous immune responses that underlie most disease pathology. Schistosoma mansoni is the primary lab model for research, and, due to the abundance and ease of harvesting, liver-derived eggs are almost exclusively used to maintain the life cycle and to study miracidia and subsequent larval stages. However, recent evidence shows that eggs from the liver or intestine have key morphometric, transcriptomic, and antigenic differences, which can profoundly affect experimental outcomes. To determine whether these differences extend to the miracidia stage, we compared miracidia hatched from mouse liver and intestine-derived eggs, sequencing their transcriptomes and assessing their unstimulated behaviors over time in an arena allowing for high-resolution tracking of miracidia behavior at a large spatiotemporal scale. We found that while transcriptomic profiles of miracidia are distinguishable based on egg tissue origin, only a small subset of genes is differentially expressed. Further, the basic, unstimulated behavior of miracidia that developed in different niches of the definitive host was significantly different. These different behavioral programs may reflect intrinsic developmental programming or differential viability and hardiness related to tissue origin. These findings underscore the importance of egg source in experimental design and interpretation, with significant implications for the maintenance of laboratory life cycles and the use of miracidia in schistosomiasis research.
- 1 January 2026
- Published by American Society of Parasitologists in Journal of Parasitology
- Vol. 112 (3) , 360-367
Tissue-Specific Origin of Eggs in the Definitive Host Drives Transcriptomic and Behavioral Differences in Schistosoma mansoni Miracidia
Schistosomiasis is a neglected tropical disease caused by human-infective schistosomes (Trematoda: Schistosoma). Intestinal schistosomiasis in sub-Saharan Africa and the Neotropics is caused primarily by Schistosoma mansoni and is transmitted by several Biomphalaria planorbid snail species. Adult male and female parasites in the definitive mammalian host pair and reside in the mesenteric vasculature; females lay eggs that traverse the intestinal wall to be excreted, but a significant proportion become trapped in host tissues, especially the liver, eliciting granulomatous immune responses that underlie most disease pathology. Schistosoma mansoni is the primary lab model for research, and, due to the abundance and ease of harvesting, liver-derived eggs are almost exclusively used to maintain the life cycle and to study miracidia and subsequent larval stages. However, recent evidence shows that eggs from the liver or intestine have key morphometric, transcriptomic, and antigenic differences, which can profoundly affect experimental outcomes. To determine whether these differences extend to the miracidia stage, we compared miracidia hatched from mouse liver and intestine-derived eggs, sequencing their transcriptomes and assessing their unstimulated behaviors over time in an arena allowing for high-resolution tracking of miracidia behavior at a large spatiotemporal scale. We found that while transcriptomic profiles of miracidia are distinguishable based on egg tissue origin, only a small subset of genes is differentially expressed. Further, the basic, unstimulated behavior of miracidia that developed in different niches of the definitive host was significantly different. These different behavioral programs may reflect intrinsic developmental programming or differential viability and hardiness related to tissue origin. These findings underscore the importance of egg source in experimental design and interpretation, with significant implications for the maintenance of laboratory life cycles and the use of miracidia in schistosomiasis research.
- Open Access
- 9 December 2025
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (12) , e1013766
Quantitative ethology of schistosome miracidia characterizes a conserved snail peptide that inhibits host recognition
Over 700 million people are at risk of contracting schistosomiasis due to regular exposure to freshwater sources where infected snails, the obligate intermediate hosts of schistosomes, are endemic. Although mass drug administration of praziquantel effectively controls the disease in most regions, achieving elimination will require reducing populations of infected snails that shed the human-infective larval stage. Considerable research effort has focused on parasite development and immunological responses after snail penetration, but comparatively little is known about the molecular and behavioral host seeking events that precede it, primarily due to technical and physical constraints. To address this gap, we developed a custom imaging and computational system for tracking and screening schistosome miracidia, the snail-infective larval form that hatches from eggs. Our system employs an array of cameras without magnification and acrylic devices that maintain miracidia within the focal plane, create a field of view over 200,000 times the area of a single miracidium, and support the formation of stable chemical gradients. Using this platform, we perform quantitative ethology of miracidia at an unprecedented scale and extract features that drive the emergent chemoklinokinetic behavior in response to snail cues. We demonstrate that miracidia accumulate at the edge of a gradient of snail cues by increasing key chemoklinokinetic features upon leaving the region of a cue, corroborating previous reports. In contrast, miracidia do not exhibit these behaviors when the cue is uniform, demonstrating that the behaviors represent a specific sensory response rather than generic neuromuscular activity. We further find that a previously identified stimulatory snail peptide only partially recapitulates the full chemoklinokinetic profile, and homologues from closely related snails elicit divergent behavioral outcomes. Notably, some of these snail peptides can mask the natural gradient of snail cues and inhibit miracidia recognition of snails. This work establishes a scalable behavioral platform for probing parasite-snail interactions and identifies a peptide scaffold that potently blocks snail recognition.
- 9 December 2025
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (12) , e1013766
Open AccessQuantitative ethology of schistosome miracidia characterizes a conserved snail peptide that inhibits host recognition
Over 700 million people are at risk of contracting schistosomiasis due to regular exposure to freshwater sources where infected snails, the obligate intermediate hosts of schistosomes, are endemic. Although mass drug administration of praziquantel effectively controls the disease in most regions, achieving elimination will require reducing populations of infected snails that shed the human-infective larval stage. Considerable research effort has focused on parasite development and immunological responses after snail penetration, but comparatively little is known about the molecular and behavioral host seeking events that precede it, primarily due to technical and physical constraints. To address this gap, we developed a custom imaging and computational system for tracking and screening schistosome miracidia, the snail-infective larval form that hatches from eggs. Our system employs an array of cameras without magnification and acrylic devices that maintain miracidia within the focal plane, create a field of view over 200,000 times the area of a single miracidium, and support the formation of stable chemical gradients. Using this platform, we perform quantitative ethology of miracidia at an unprecedented scale and extract features that drive the emergent chemoklinokinetic behavior in response to snail cues. We demonstrate that miracidia accumulate at the edge of a gradient of snail cues by increasing key chemoklinokinetic features upon leaving the region of a cue, corroborating previous reports. In contrast, miracidia do not exhibit these behaviors when the cue is uniform, demonstrating that the behaviors represent a specific sensory response rather than generic neuromuscular activity. We further find that a previously identified stimulatory snail peptide only partially recapitulates the full chemoklinokinetic profile, and homologues from closely related snails elicit divergent behavioral outcomes. Notably, some of these snail peptides can mask the natural gradient of snail cues and inhibit miracidia recognition of snails. This work establishes a scalable behavioral platform for probing parasite-snail interactions and identifies a peptide scaffold that potently blocks snail recognition.
- 15 September 2025
- Published by EMBL-EBI
Quantitative ethology of schistosome miracidia characterizes a conserved snail peptide that inhibits host recognition
BioStudies – one package for all the data supporting a study
- 15 September 2025
- Published by EMBL-EBI
Quantitative ethology of schistosome miracidia characterizes a conserved snail peptide that inhibits host recognition
BioStudies – one package for all the data supporting a study
- Open Access
Tissue-specific distribution of eggs in the definitive host drives transcriptomic and behavioral differences in Schistosoma mansoni miracidia
Schistosomiasis is a neglected tropical disease caused by human-infective schistosomes (Trematoda: Schistosoma ). Intestinal schistosomiasis in sub-Saharan Africa and the Neotropics is caused primarily by Schistosoma mansoni and is transmitted by several Biomphalaria planorbid snail species. Adult male and female parasites in the definitive mammalian host pair and reside in the mesenteric vasculature; females lay eggs that traverse the intestinal wall to be excreted, but a significant proportion become trapped in host tissues, especially the liver, eliciting granulomatous immune responses that underlie most disease pathology. S. mansoni is the primary lab model for research and, due to the abundance and ease of harvesting, liver-derived eggs are almost exclusively used to maintain the life cycle and to study miracidia and subsequent larval stages. However, recent evidence shows that eggs from the liver or intestine have key morphometric, transcriptomic, and antigenic differences, which can profoundly affect experimental outcomes. To determine whether these differences extend to the miracidia stage, we compared miracidia hatched from mouse liver and intestine-derived eggs, sequencing their transcriptomes and assessing their unstimulated behaviors over time in an arena allowing for high-resolution tracking of miracidia behavior at a large spatiotemporal scale. We found that while transcriptomic profiles of miracidia are distinguishable based on egg tissue origin, only a small subset of genes is differentially expressed. Further, basic, unstimulated behavior of miracidia that developed in different niches of the definitive host was significantly different. These different behavioral programs may reflect intrinsic developmental programming or differential viability and hardiness related to tissue origin. These findings underscore the importance of egg source in experimental design and interpretation, with significant implications for the maintenance of laboratory life cycles and the use of miracidia in schistosomiasis research.
Open AccessTissue-specific distribution of eggs in the definitive host drives transcriptomic and behavioral differences in Schistosoma mansoni miracidia
Schistosomiasis is a neglected tropical disease caused by human-infective schistosomes (Trematoda: Schistosoma ). Intestinal schistosomiasis in sub-Saharan Africa and the Neotropics is caused primarily by Schistosoma mansoni and is transmitted by several Biomphalaria planorbid snail species. Adult male and female parasites in the definitive mammalian host pair and reside in the mesenteric vasculature; females lay eggs that traverse the intestinal wall to be excreted, but a significant proportion become trapped in host tissues, especially the liver, eliciting granulomatous immune responses that underlie most disease pathology. S. mansoni is the primary lab model for research and, due to the abundance and ease of harvesting, liver-derived eggs are almost exclusively used to maintain the life cycle and to study miracidia and subsequent larval stages. However, recent evidence shows that eggs from the liver or intestine have key morphometric, transcriptomic, and antigenic differences, which can profoundly affect experimental outcomes. To determine whether these differences extend to the miracidia stage, we compared miracidia hatched from mouse liver and intestine-derived eggs, sequencing their transcriptomes and assessing their unstimulated behaviors over time in an arena allowing for high-resolution tracking of miracidia behavior at a large spatiotemporal scale. We found that while transcriptomic profiles of miracidia are distinguishable based on egg tissue origin, only a small subset of genes is differentially expressed. Further, basic, unstimulated behavior of miracidia that developed in different niches of the definitive host was significantly different. These different behavioral programs may reflect intrinsic developmental programming or differential viability and hardiness related to tissue origin. These findings underscore the importance of egg source in experimental design and interpretation, with significant implications for the maintenance of laboratory life cycles and the use of miracidia in schistosomiasis research.
- Open Access
Quantitative ethology of schistosome miracidia characterizes a conserved snail peptide that inhibits penetration
Over 700 million people are at risk of contracting schistosomiasis due to regular exposure to freshwater sources where infected snails, the obligate intermediate hosts of schistosomes, are endemic. Although mass drug administration of praziquantel effectively controls the disease in most regions, achieving elimination will require reducing populations of infected snails that shed the human-infective larval stage. Considerable effort has focused on parasite development and immunological responses after snail penetration, but comparatively little is known about the molecular and behavioral host seeking events that precede it, primarily due to technical and physical constraints. To address this gap, we developed a custom imaging and computational system for tracking and screening schistosome miracidia, the snail-infective larval form that hatches from eggs. Our system employs an array of cameras without magnification and acrylic devices that maintain miracidia within the focal plane, create a field of view over 200,000 times the area of a single miracidium, and support the formation of stable chemical gradients. Using this platform, we perform quantitative ethology of miracidia at an unprecedented scale and extract features that drive the emergent chemoklinokinetic behavior in response to snail cues. We demonstrate that miracidia accumulate at the edge of a gradient of snail cues by increasing key chemoklinokinetic features upon leaving the region of a cue, corroborating previous reports. In contrast, miracidia do not exhibit these behaviors when the cue is uniform, demonstrating that they represent a specific sensory response rather than generic neuromuscular activity. We further find that a previously identified stimulatory snail peptide only partially recapitulates the full chemoklinokinetic profile, and homologues from closely related species elicit divergent behavioral outcomes. Notably, some of these snail peptides can mask a natural gradient and inhibit miracidia penetration of snails. This work establishes a scalable behavioral platform for probing parasite- snail interactions and identifies a peptide scaffold that potently blocks snail penetration.
Open AccessQuantitative ethology of schistosome miracidia characterizes a conserved snail peptide that inhibits penetration
Over 700 million people are at risk of contracting schistosomiasis due to regular exposure to freshwater sources where infected snails, the obligate intermediate hosts of schistosomes, are endemic. Although mass drug administration of praziquantel effectively controls the disease in most regions, achieving elimination will require reducing populations of infected snails that shed the human-infective larval stage. Considerable effort has focused on parasite development and immunological responses after snail penetration, but comparatively little is known about the molecular and behavioral host seeking events that precede it, primarily due to technical and physical constraints. To address this gap, we developed a custom imaging and computational system for tracking and screening schistosome miracidia, the snail-infective larval form that hatches from eggs. Our system employs an array of cameras without magnification and acrylic devices that maintain miracidia within the focal plane, create a field of view over 200,000 times the area of a single miracidium, and support the formation of stable chemical gradients. Using this platform, we perform quantitative ethology of miracidia at an unprecedented scale and extract features that drive the emergent chemoklinokinetic behavior in response to snail cues. We demonstrate that miracidia accumulate at the edge of a gradient of snail cues by increasing key chemoklinokinetic features upon leaving the region of a cue, corroborating previous reports. In contrast, miracidia do not exhibit these behaviors when the cue is uniform, demonstrating that they represent a specific sensory response rather than generic neuromuscular activity. We further find that a previously identified stimulatory snail peptide only partially recapitulates the full chemoklinokinetic profile, and homologues from closely related species elicit divergent behavioral outcomes. Notably, some of these snail peptides can mask a natural gradient and inhibit miracidia penetration of snails. This work establishes a scalable behavioral platform for probing parasite- snail interactions and identifies a peptide scaffold that potently blocks snail penetration.
- Open Access
- 20 March 2025
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 27, 100588
A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening
- 20 March 2025
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 27, 100588
Open AccessA graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening
- Open Access
A GRAPHICAL USER INTERFACE FOR WRMXPRESS 2.0 STREAMLINES HELMINTH PHENOTYPIC SCREENING
Image-based phenotypic screening is a fundamental technique used to better understand the basic biology of helminths and advance discovery of new anthelmintics. Miniaturization of screening platforms and automated microscopy have led to a surge in imaging data and necessitated software to organize and analyze these data. Traditionally, these analyses are performed remotely on high-performance computers, often requiring an understanding of a command-line interface (CLI) and the ability to write scripts to control the software or job scheduler. Requiring access to specialized computing equipment and advanced computational skills raises the barrier to entry for these sorts of studies. The development of efficient, performant computer and graphical processing units for personal computers and cheaper imaging solutions has made the requirement of remote servers superfluous for many small to medium-scale screens, but most analytical software still require interaction with a CLI. To democratize the analysis of image-based phenotypic screens, we have developed a graphical user interface (GUI) for wrmXpress, a tool that integrates many popular computational pipelines for analyzing imaging data of parasitic and free-living worms. The GUI operates on any personal computer using the operating system’s native web browser, allowing users to configure and run analyses using a point-and-click approach. Containerization of the application eliminates the need to install specialized programming libraries and dependencies, further increasing the ease of use. GUI development required a substantial reorganization of the wrmXpress backend codebase, which allowed for the addition a new pipeline for high-resolution tracking of worm behavior, and we demonstrate its functionality by showing that praziquantel modulates the behavior of Schistosoma mansoni miracidia. These advances make cutting-edge analyses of image-based phenotyping of worms more equitable and accessible.
Open AccessA GRAPHICAL USER INTERFACE FOR WRMXPRESS 2.0 STREAMLINES HELMINTH PHENOTYPIC SCREENING
Image-based phenotypic screening is a fundamental technique used to better understand the basic biology of helminths and advance discovery of new anthelmintics. Miniaturization of screening platforms and automated microscopy have led to a surge in imaging data and necessitated software to organize and analyze these data. Traditionally, these analyses are performed remotely on high-performance computers, often requiring an understanding of a command-line interface (CLI) and the ability to write scripts to control the software or job scheduler. Requiring access to specialized computing equipment and advanced computational skills raises the barrier to entry for these sorts of studies. The development of efficient, performant computer and graphical processing units for personal computers and cheaper imaging solutions has made the requirement of remote servers superfluous for many small to medium-scale screens, but most analytical software still require interaction with a CLI. To democratize the analysis of image-based phenotypic screens, we have developed a graphical user interface (GUI) for wrmXpress, a tool that integrates many popular computational pipelines for analyzing imaging data of parasitic and free-living worms. The GUI operates on any personal computer using the operating system’s native web browser, allowing users to configure and run analyses using a point-and-click approach. Containerization of the application eliminates the need to install specialized programming libraries and dependencies, further increasing the ease of use. GUI development required a substantial reorganization of the wrmXpress backend codebase, which allowed for the addition a new pipeline for high-resolution tracking of worm behavior, and we demonstrate its functionality by showing that praziquantel modulates the behavior of Schistosoma mansoni miracidia. These advances make cutting-edge analyses of image-based phenotyping of worms more equitable and accessible.